HS
HighVista Strategies Portfolio holdings
AUM
$272M
This Quarter Return
+12.21%
1 Year Return
+24.34%
3 Year Return
+176.43%
5 Year Return
+271.23%
10 Year Return
+682.63%
AUM
$290M
AUM Growth
+$290M
(+5.9%)
Cap. Flow
-$2.16M
Cap. Flow
% of AUM
-0.74%
Top 10 Holdings %
Top 10 Hldgs %
25.51%
Holding
174
New
37
Increased
46
Reduced
48
Closed
32
Top Buys
| 1 |
GE Vernova
GEV
|
$3.75M |
| 2 |
Amgen
AMGN
|
$3.25M |
| 3 |
Protagonist Therapeutics
PTGX
|
$3.07M |
| 4 |
Amazon
AMZN
|
$2.65M |
| 5 |
Edgewise Therapeutics
EWTX
|
$2.37M |
Top Sells
| 1 |
Insmed
INSM
|
$5.94M |
| 2 |
ETRN
Equitrans Midstream Corporation Common Stock
ETRN
|
$4.02M |
| 3 |
CERE
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
|
$3.97M |
| 4 |
Merus
MRUS
|
$2.14M |
| 5 |
Meta Platforms (Facebook)
META
|
$2.06M |
Sector Composition
| 1 | Healthcare | 46.45% |
| 2 | Technology | 15.69% |
| 3 | Consumer Discretionary | 9.1% |
| 4 | Industrials | 4.98% |
| 5 | Financials | 4.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Corbus Pharmaceuticals
CRBP
$121M
| $1.55M | 0.54% |
75,292
+36,499
| +94% | +$753K |
|
77
Broadcom
AVGO
$1.42T
| $1.54M | 0.53% |
+8,900
| New | +$1.54M |
|
78
Teva Pharmaceuticals
TEVA
$21.5B
| $1.53M | 0.53% |
85,100
-51,400
| -38% | -$926K |
|
79
Royal Caribbean
RCL
$96.4B
| $1.53M | 0.53% |
+8,600
| New | +$1.53M |
|
80
ServiceNow
NOW
$191B
| $1.52M | 0.52% |
+1,700
| New | +$1.52M |
|
81
Booking.com
BKNG
$181B
| $1.5M | 0.52% |
357
-400
| -53% | -$1.68M |
|
82
Crinetics Pharmaceuticals
CRNX
$3.26B
| $1.48M | 0.51% |
28,911
-6,326
| -18% | -$323K |
|
83
TKO Group
TKO
$15.3B
| $1.45M | 0.5% |
+11,700
| New | +$1.45M |
|
84
Lennar Class A
LEN
$34.7B
| $1.44M | 0.5% |
+7,700
| New | +$1.44M |
|
85
Arvinas
ARVN
$580M
| $1.43M | 0.49% |
58,001
+6,879
| +13% | +$169K |
|
86
Netflix
NFLX
$521B
| $1.42M | 0.49% |
2,000
+200
| +11% | +$142K |
|
87
Indivior
INDV
$3.08B
| $1.4M | 0.48% |
142,634
-36,202
| -20% | -$357K |
|
88
Structure Therapeutics
GPCR
$1.14B
| $1.39M | 0.48% |
31,718
-3,410
| -10% | -$150K |
|
89
Roivant Sciences
ROIV
$8.6B
| $1.33M | 0.46% |
115,326
-11,415
| -9% | -$132K |
|
90
Eli Lilly
LLY
$661B
| $1.33M | 0.46% |
1,500
| – | – |
|
91
Philip Morris
PM
$254B
| $1.32M | 0.46% |
10,900
-600
| -5% | -$72.8K |
|
92
Uber
UBER
$194B
| $1.32M | 0.46% |
+17,600
| New | +$1.32M |
|
93
T-Mobile US
TMUS
$284B
| $1.32M | 0.46% |
6,400
-5,500
| -46% | -$1.13M |
|
94
Elevance Health
ELV
$72.4B
| $1.3M | 0.45% |
+2,500
| New | +$1.3M |
|
95
RXO
RXO
$2.62B
| $1.29M | 0.44% |
+46,000
| New | +$1.29M |
|
96
GE HealthCare
GEHC
$33B
| $1.24M | 0.43% |
13,200
-2,900
| -18% | -$272K |
|
|
SWTX
97
DELISTED
SpringWorks Therapeutics
SWTX
| $1.15M | 0.4% |
35,852
-15,135
| -30% | -$485K |
|
98
Terns Pharmaceuticals
TERN
$651M
| $1.09M | 0.38% |
130,966
-17,234
| -12% | -$144K |
|
99
Pinduoduo
PDD
$177B
| $1.09M | 0.38% |
8,078
+5,500
| +213% | +$741K |
|
100
Janux Therapeutics
JANX
$1.38B
| $1.07M | 0.37% |
23,472
+140
| +0.6% | +$6.36K |
|